Romosozumab improves shear bone strength in postmenopausal women with osteoporosis in BCT substudies
Romosozumab May Help Spinal Fusion Surgery Last Longer
This retrospective secondary analysis of phase 2 and 3 randomized trial data evaluated romosozumab in postmenopausal women with low bone den…
A bone drug may make spinal fusion surgery more secure for women with weak bones, new virtual tests suggest.
Antiresorptive and Anabolic Agents Improve Bone Microarchitecture in Postmenopausal Women With Type 2 Diabetes: Pilot RCT
Diabetes Weakens Bones: One Drug Builds Them Back
This pilot randomized controlled trial evaluated antiresorptive and anabolic agents in 129 postmenopausal women with Type 2 Diabetes.
Building new bone tissue with a specific daily shot works better than just protecting existing bone for women with diabetes.
In male osteoporosis, anabolic therapies improved lumbar spine and hip BMD more than antiresorptives at 12 months
Men Get Osteoporosis Too — and Now We Know Which Drugs Win
This Bayesian network meta-analysis evaluated antiresorptive and anabolic pharmacological interventions in men with osteoporosis.
A new analysis of 18 clinical trials finds that bone-building drugs may outperform bone-preserving drugs for men with osteoporosis, especial…